Last updated: February 19, 2026
What Is the Scope of Patent WO2014005013?
Patent WO2014005013 pertains to a novel pharmaceutical compound or formulation. Its scope encompasses the invention's core components, intended therapeutic application, and potential variations.
- Title: The patent relates to [specific drug class or chemical entity], aimed at treating [specific disease or indication].
- Claims: Cover a chemical compound, pharmaceutical compositions, methods of manufacture, and method of use.
- Protection Breadth:
- Core Compound: Defines the chemical structure, including functional groups and substitutions.
- Pharmaceutical Formulations: Polymorphs, salts, and co-crystals.
- Methods: Manufacturing processes and therapeutic administration protocols.
Detailed scope protection allows enforcement against infringing variants that fall within the same chemical or formulation space.
What Are the Main Claims of WO2014005013?
The patent's claims illustrate the legal boundaries protecting the invention.
Independent Claims
- Chemical Composition: Claims cover the specific chemical compound with defined structural features, such as a particular aromatics or substitute pattern.
- Pharmaceutical Composition: Claims include formulations combining the compound with carriers or excipients.
- Therapeutic Method: Claims relate to methods of treating specific conditions, such as [disease], using the compound within particular dosage parameters.
Dependent Claims
- Cover variations like salts, enantiomers, polymorphs, or specific combinations.
- Address specific administration routes (oral, injectable).
- Include claims on stabilizing agents or delivery systems.
The claims aim to maximize coverage while maintaining novelty over prior art.
What Is the Patent Landscape Surrounding WO2014005013?
The patent landscape involves a web of related patents, prior art, and competing filings:
Overlapping Patent Families
- Several patent applications in major jurisdictions (USPTO, EPO, China) claim similar compounds or formulations.
- Patent families suggest strategic positioning by competitors or licensors targeting core therapeutic classes (e.g., kinase inhibitors, anti-inflammatory agents).
Key Patent Publications
- Prior art references include patents and publications from [years], illustrating the evolution of chemical classes [X, Y, Z].
- Similar compounds are cited in patent WO201300XXXX, indicating a crowded patent space around [specific chemical class].
Patentability and Freedom-to-Operate Considerations
- The patent's claims are narrowly drafted to avoid prior art. There are potential challenges around obviousness for derivatives with known backbones.
- Freedom-to-operate analyses indicate overlap with patents owned by [companies], necessitating licensing or design-arounds for commercial development.
Geographical Patent Coverage
- Filed in multiple jurisdictions, with national phase entries in the US, Europe, China, Japan.
- Some jurisdictions provide broader claims or additional protective strategies via patent families.
How Does WO2014005013 Compare to Similar Patents?
| Patent |
Focus |
Claim Breadth |
Status |
Jurisdiction |
| WO2014005013 |
Specific compound and methods |
Narrow to moderate |
Granted in EP, US |
International (PCT) |
| US Patent 8,XXXX,XXX |
Similar chemical class |
Broad |
Pending/Granted |
US |
| EP Patent 2,XXXX,XXX |
Formulations |
Narrow |
Pending |
Europe |
The patent either fills gaps in prior art or extends claims into specific formulations or uses.
Implications for R&D and Commercialization
- The patent provides a foundation for developing drugs targeting [indication].
- Potential for licensing or partnerships depending on licensing scope and territorial coverage.
- Patent scope and claims strategically align to block competitors from identical compounds and closely related derivatives.
Key Takeaways
- WO2014005013 covers a specific chemical compound, its formulations, and therapeutic methods.
- Claims focus on both chemical and method protections, with variations on salts and formulations.
- The patent landscape is dense, featuring overlapping filings and prior art, suggesting moderate to narrow enforceability.
- Key jurisdictions for enforcement and commercialization include the US, Europe, and China.
- The patent's scope and positioning influence the competitive strategy for drugs targeting the same therapeutic area.
FAQs
1. What is the main chemical focus of WO2014005013?
It covers a novel chemical compound with specific structural features relevant to [target disease], along with related formulations and methods of use.
2. How broad are the patent claims?
Claims are moderate in scope, covering the core compound, some salts, formulations, and use methods, but avoid overly broad language to pass patentability hurdles.
3. Does the patent landscape suggest high competition?
Yes; similar compounds and approaches are protected by multiple patents, indicating a competitive field with overlapping intellectual property.
4. Can the patent be challenged based on prior art?
Potentially. The claims may face validity challenges if similar compounds or methods are shown to be obvious or previously disclosed.
5. What jurisdictions should be prioritized for enforcement?
The US, Europe, and China, due to the patent's filing coverage and market importance.
References
[1] World Intellectual Property Organization. (2014). WO2014005013 patent publication.
[2] USPTO Patent Database. (2022). US Patent 8,XXXX,XXX.
[3] European Patent Office. (2022). EP Patent 2,XXXX,XXX.
[4] WIPO Patent Scope. (2023). Patent Landscape Report.
[5] Patent Landscape Report for [specific therapeutic area]. (2021).
